Grupo Germano de Sousa

Grupo Germano de Sousa, also referred to as GGS, is a medical laboratory group headquartered in Portugal. It provides a wide range of diagnostic testing services that support clinical decision‑making for patients and healthcare providers across the country. The organization operates a network of laboratories that process routine and specialized analyses, contributing to the national healthcare infrastructure. Its services are utilized by both public hospitals and private clinics seeking timely and accurate test results.

In February 2022, GGS experienced a cyberattack that disrupted its information systems and forced the temporary closure of its laboratory facilities nationwide. The incident prevented the delivery of test results for thousands of patients, with reports indicating that over 12,000 individuals lacked critical results on the day of the attack. Although the organization stated that patient data remained uncompromised, the outage required a complete reconstruction of its IT infrastructure to restore operations. Services began to resume gradually in the northern regions, with full system functionality anticipated within 24 to 48 hours after reactivation.

The cyberattack highlighted GGS’s role as a major provider of laboratory diagnostics in Portugal and demonstrated the operational impact of IT disruptions on laboratory services. By describing the incident as a criminal act targeting its business, the organization noted that patient data remained uncompromised and that a complete reconstruction of its systems was required. Services resumed gradually starting in the northern regions, with administrators anticipating rapid result dissemination once the systems were back online. The episode illustrates how a large‑scale laboratory organization can manage extensive service interruptions while working to restore testing capacity across the country.